3
Sciotti, R. J.; Bavari, S.; Burnett, J. C. Solaja, B. A. J. Med.
Chem. 2013, 56, 5860.
4. Sanjay R. P.; Rahul G.; Sangamwar, A. T. Eur. J. Med. Chem.
2015, 93, 511.
5. (a) Musiol, R. Curr. Pharm. Des. 2013, 19, 1835-1849; (b) Hu, L.
M.; Yan, S.; Luo, Z. G.; Han, X.; Wang, Y. J.; Wang, Z. Y.; Zeng,
C. C. Molecules 2012, 17, 10652.
6. a) Krishnakumar, V.; Khan, F. R. N.; Mandal, B. K.; Mitta, S.;
Dhasamandha, R.; Govindan, V. N. Res.Chem. Intermed. 2012,
38, 1819; (b) Xia, L. K.; Idhayadhulla, A.; Lee, Y. R.; Kim, S. H.;
Wee, Y. J. Comb. Sci. 2014, 16, 333; (c) Makawana, J. A.;
Sangani, C. B.; Teraiya, S. B.; Zhu, H. L. Med. Chem. Res. 2014,
23 471.
7. (a) Vandekerckhove, S.; Tran, H. G.; Desmet, T.; D'hooghe, M.
Bioorg. Med. Chem. Lett. 2013, 23, 4641; (b) Havaldar, F. H.;
Burudkar, S. M. Indian J. Heterocycl. Chem. 2012, 22, 197.
8. (a) Solomon, V. R.; Lee, H. Curr. Med. Chem. 2011, 18, 1488; (b)
Chen, M.; Chen, H.; Ma, J.W.; Liu, X.Y.; Zhang, S.Y. Bioorg.
Med. Chem. Lett. 2014, 24, 2867; (b) Marganakop, S. B.; Kamble,
R. R.; Hoskeri, J.; Prasad, D. J.; Meti, G. Y. Med. Chem. Res.
2014, 23, 2727.
Figure 1. ORTEP diagram of 9e and 9f
9. Bridhkoti, J. P.; Gahlaut, R.; Joshi, H. C.; Pant, S. J. Lumin. 2011,
131, 1869.
10. Nedeltchev, A. K.; Han, H.; Bhowmik, P. K. Tetrahedron 2010,
66, 9319.
11. Achan, J.; Talisuna, A. O.; Erhart, A.; Yeka, A.; Tibenderana, J.
K.; Baliraine, F. N.; Rosenthal, P. J.; D’Alessandro, U. Malar. J.
2011, 10, 144.
12. For a review see: Campoli-Richards, D. M.; Monk, J. P.; Price, A.;
Benfield, P.; Todd, P. A.; Ward, A. Drug 1988, 35, 373.
13. For a review see: North, D. S.; Fish, D. N.; Redington, J. J.
Pharmacotherapy 1998, 18, 915.
14. Skraup, H. Chem. Ber. 1880, 13, 2086
Scheme 2. Plausible mechanism for the formation of pyrrolo-[3,4-
b]quinolines 9
15. Combes, A. Bull. Chim. Soc. France 1888, 49, 89.
16. (a) Friedlander, P. Chem. Ber. 1882, 15, 2572. (b) For a review
see: Marco-Contelles, J.; Pérez-Mayoral, E.; Samadi, A.;
Carreiras, M. C.; Soriano, E. Chem. Rev. 2009, 109, 2652.
17. Pfitzinger, W. J. Prakt. Chem. 1886, 33, 100.
18. Doebner, O.; von Miller, W. Chem. Ber. 1881, 14, 2812.
19. (a) Povarov, L. S.; Mikhailov, B. M. Izv. Akad. Nauk SSSR, Ser.
Khim. 1963, 953; (b) Povarov, L. S. Russ. Chem. Rev. 1967, 36,
656; For reviews, see: (c) Kouznetsov, V. V. Tetrahedron 2009,
65, 2721; (d) Bello D, Ramón R, Lavilla R. Curr.Org.Chem. 2010,
14, 332.
In conclusion, N-alkynylaldehyde 6 was obtained in five steps
in good yield from readily available (S)-phenylalanine. The
BF3.OEt2 catalyzed intramolecular Povarov reaction of 6 with
various substituted arylamines afforded a series of pyrrolo[3,4-
b]quinolines in excellent yields. To the best of our knowledge,
this is the first report for the preparation of 3-benzyl-2-tosyl-2,3-
dihydro-1H-pyrrolo[3,4-b]
intermediates for the synthesis of D-ring modified luotonin
inspired heterocyclic hybrids.
quinolines,
which are
key
20. For Povarov reactions with alkenes as dienophiles see: (a)
Laschat, S.; Lauterweine, J. J. Org. Chem.1993, 58, 2856; (b)
Beifuss, U.; Herde, A.; Ledderhose, S. Chem. Commun. 1996,
1213; (c) Znang, D.; Kiselyov, A. S. Synlett. 2001, 1173; (d)
Sundararajan, G.; Prabagaran, N.; Varghese, B. Org. Lett. 2001, 3,
1973; (e) Magomedov, N. A. Org. Lett. 2003, 5, 2509.
21. For Povarov reactions with alkynes as dienophiles see: (a)
Leardini, R.; Nanni, D.; Tundo, A.; Zanardi, G.; Ruggieri, F. J.
Org. Chem. 1992, 57, 1842; (b) Bortoloffl, B.; Leardini, R.;
Nanni, D.; Zanardi, G. Tetrahedron 1993, 49, 10157; (c) Baudelle,
R.; Melnyk, P.; Deprez, B.; Tartar, A. Tetrahedron 1998, 54,
4125.
Acknowledgments
This Project was funded by the National Plan for Science,
Technology and Innovation (MAARIFAH), King Abdulaziz City
for Science and Technology, Kingdom of Saudi Arabia, Award
Number (12MED2503-02).
22. a) Leardini, R.; Nanni, D.; Tundo, A.; Zanardi, G.; Ruggieri, F. J.
Org. Chem. 1992, 57, 1842; (b) Kouznetsov, V. V.; Melendez
Gomez, C. M.; Urbina Gonzalez, J. M.; Stashenko, E. E.; Bahsas,
A.; Amaro Luis, J. J. Het. Chem. 2007, 44, 551; (c) Tanaka, S. Y.;
Yasuda, M.; Baba, A. J. Org. Chem. 2005, 71, 800; (d)
Kobayashi, S.; Ishitani, H.; Nagayama, S. Chem. Lett. 1995, 24,
423 and references cited therein.
Supplementary Material
Supplementary data associated with this article can be found in
the online version, at http://
23. (a) Shindoh, N.; Tokuyama, H.; Takasu, K. Tetrahedron Lett.
2007, 48, 4749; (b) Shindoh, N.; Tokuyama, H.; Takemoto, Y.;
Takasu, K. J. Org. Chem. 2008, 73, 7451.
References and notes
1. (a) Keri, R. S.; Patil, S. A.; Biomed. Pharmacother. 2014, 68,
1161; (b) Simoes, J. B.; de Fatima, A.; Sabino, A. A.; Almeida
Barbosa, L. C.; Fernandes, S. A. RSC Adv. 2014, 4, 18612; (c) Li,
H.; Wang, C.; Huang, H.; Xu, X.; Li, Y. Tetrahedron Lett. 2011,
52, 1108.
2. (a) Kaur, K.; Jain, M.; Reddy, R. P.; Jain, R. Eur. J. Med. Chem.
2010, 45, 3245; (b) Sharma, R.; Patil, S.; Maurya, P. Environ. Res.
2014, 25, 189; (c) N'Da, D.D.; Smith, P. J. Med. Chem. Res. 2014,
23, 1214.
24. Kacprzak, K. M. Ramawat, K. G.; Mérillon, J. M. (Eds.) 2013
Natural Products (643–682) Heidelberg, Berlin: Springer.
25. Dallavalle, S.; Merlini, L.; Beretta, G.; Tinelli, S.; Zunino, F.
Bioorg. Med. Chem. Lett. 2004, 14, 5757; (b) Ciufolini, M. A.;
Roschangar, F. Tetrahedron 1997, 53, 11049; (c) Chavan, S. P.;
Venkatraman, M. S. Tetrahedron Lett. 1998, 39, 6745.
26. Osborne, D.; Stevenson, P. J. Tetrahedron Lett. 2002, 43, 5469.
27. Twin, H.; Batey, R. A. Org. Lett. 2004, 6, 4913.
28. (a) Arumugam, N.; Almansour, A. I.; Suresh Kumar, R.; Perumal,
S.; Ghabbour, H. G.; Fun, H.-K. Tetrahedron Lett. 2013, 55, 2515;
(b) Almansour, A. I.; Arumugam, N.; Suresh Kumar, R.;
Padmanaban, R.; Rajamanikandan, V. B.; H. A.; Fun, H.-K. J.
Mol. Struct.2014, 1068, 283; (c) Almansour, A. I.; Arumugam, N.;
3. Inam, A.; Siddiqui, S. M.; Macedo, T. S.; Moreira, D. R. M.;
Leite, A. C. L.; Soares, M. B. P.; Azam, A. Eur. J. Med. Chem.
2014, 75, 67; (b) Opsenica, I.M.; Tot, M.; Gomba, L.; Nuss, J. E.;